2,600
Views
3
CrossRef citations to date
0
Altmetric
Clinical Trial

Factors associated with Noninvasive ventilation compliance in patients with ALS/MND

, , , , &
Pages 40-47 | Received 04 Jan 2021, Accepted 15 Mar 2021, Published online: 04 Aug 2021

References

  • Rabkin J, Ogino M, Goetz R, et al. Tracheostomy with invasive ventilation for ALS patients: neurologists’ roles in the US and Japan. Amyotroph Lateral Scler Front Degener. 2013;14:116–23.
  • Bradley WG, Anderson F, Bromberg M, Gutmann L, Harati Y, Ross M, et al. Current management of ALS: comparison of the ALS CARE database and the AAN Practice Parameter. Neurology. 2001;57:500–4.
  • Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5:140–7.
  • Radunovic A, Annane D, Rafiq MK, Brassington R, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2017;10:CD004427.
  • Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73:1218–26.
  • Lechtzin N, Cudkowicz ME, de Carvalho M, et al. Respiratory measues in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2018;19:321–30.
  • Heiman-Patterson TD, Cudkowicz ME, De Carvalho M, Genge A, Hardiman O, Jackson CE, et al. Understanding the use of NIV in ALS: results of an international ALS specialist survey. Amyotroph Lateral Scler Front Degener. 2018;19:331–41.
  • The National Institute for Health and Care Excellence (NICE). Motor Neurone Disease: assessment and management: NICE Guideline NG42: methods, evidence and recommendations. Lake Mary, FL: National Clinical Guideline Center; 2016.
  • Jackson CE, Lovitt S, Gowda N, Anderson F, Miller RG. Factors correlated with NPPV use in ALS. Amyotroph Lateral Scler. 2006;7:80–5.
  • Thakore NJ, Lapin BR, Pioro EP, Aboussouan LS. Variation in noninvasive ventilation use in amyotrophic lateral sclerosis. Neurology 2019;93:e306–e316.
  • Vitacca M, Montini A, Lunetta C, Banfi P, Bertella E, De Mattia E, et al. Impact of an early respiratory care programme with non‐invasive ventilation adaptation in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25:556–e33.
  • Carratu P, Spicuzza L, Cassano A, Maniscalco M, Gadaleta F, Lacedonia D, et al. Early treatment with noninvasive positive pressure ventilation prolongs survival in amyotrophic lateral sclerosis patients with nocturnal respiratory insufficiency. Orphanet J. Rare Dis 2009;4:10.
  • Lechtzin N, Scott Y, Busse AM, Clawson LL, Kimball R, Wiener CM. Early use of non‐invasive ventilation prolongs survival in subjects with ALS. Amyotroph. Lateral Scler. 2007;8:185–8.
  • Jacobs TL, Brown DL, Baek J, Migda EM, Funckes T, Gruis KL. Trial of early noninvasive ventilation for ALS: a pilot placebo‐controlled study. Neurology. 2016;87:1878–83.
  • Farrero E. Impact of early non‐invasive ventilation in amyotrophic lateral sclerosis: a randomized controlled trial. Identifier NCT01641965. Available from URL: Clinicaltrials.gov. 2016,
  • Kasarskis EJ, Mendiondo MS, Wells S, Malguizo MS, Thompson M, Healey M, et al. ALS Nutrition/NIV Study Group. The ALS Nutrition/NIV Study: design, feasibility, and initial results. Amyotroph Lateral Scler. 2011;12:17–25.